You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
MMprofiler for prognostic risk classification in multiple myeloma
Medtech innovation briefing
Reference number:
MIB270
Published:
10 August 2021
Download (PDF)
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing
Regulatory information
MMprofiler is a CE-marked IVD (IVDD Annex II List A) in vitro diagnostic device.
Next page
Equality considerations
Previous page
The technology
Back to top